Clinical Trial Update: Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of vildagliptin in subjects with impaired glucose tolerance (prediabetes); the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Prediabetes

Drugs mentioned

• Vildagliptin (Galvus) (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Prediabetic State | Phase 3 | Status: COMPLETED